Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Receivables - Net (2016 - 2025)

Avanos Medical's Receivables - Net history spans 11 years, with the latest figure at $131.9 million for Q3 2024.

  • For Q3 2024, Receivables - Net fell 9.16% year-over-year to $131.9 million; the TTM value through Sep 2024 reached $131.9 million, down 9.16%, while the annual FY2023 figure was $142.8 million, 14.95% down from the prior year.
  • Receivables - Net for Q3 2024 was $131.9 million at Avanos Medical, up from $128.1 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $167.9 million in Q4 2022 and bottomed at $69.7 million in Q3 2020.
  • The 5-year median for Receivables - Net is $137.8 million (2020), against an average of $133.3 million.
  • The largest annual shift saw Receivables - Net tumbled 56.57% in 2020 before it soared 68.58% in 2021.
  • A 5-year view of Receivables - Net shows it stood at $113.2 million in 2020, then grew by 15.9% to $131.2 million in 2021, then increased by 27.97% to $167.9 million in 2022, then dropped by 14.95% to $142.8 million in 2023, then dropped by 7.63% to $131.9 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Receivables - Net are $131.9 million (Q3 2024), $128.1 million (Q2 2024), and $131.3 million (Q1 2024).